Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Nervous and Mental Disease|March 27, 2024
Mixed Connective Tissue Disease Presenting With Psychosis-A Case ReportNikhil Tondehal, Arnab Sengupta, Kavya Mohankumar, et al.
Acta Scientific Neurology|March 25, 2025
EEG-Spectra-Guided Personalized rTMS in PTSD with Co-occurring Psychiatric Disorders: A Case SeriesKavya Mohankumar, Siddharth Karthikeya, Shaurya Mahajan, et al.
Current Neuropharmacology|June 23, 2026
Tobacco and Nicotine Dependence Vulnerability as a Function of Dopaminergic Dysregulation: Proposing a Novel Strategy to Promote Neurotransmitter HomeostasisKenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Psychology Research and Behavior Management|February 19, 2026
Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction RecoveryKenneth Blum, Mark S Gold, Nicole Jafari, et al.
Substance Use & Misuse|February 2, 2026
The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and "Chill-out" or Escapism DrugKai Uwe Lewandrowski, Kenneth Blum, Sergio Schmidt, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
British Journal of Healthcare and Medical Research|May 8, 2026
Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?Kenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Current Pharmaceutical Biotechnology|March 14, 2026
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and AnxietyKenneth Blum, Alexander P L Lewandrowski, Alireza Sharafshah, et al.
Research Square|December 3, 2025
Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis MedicinalsKenneth Blum, Alireza Sharafshah, Jag Khalsa, et al.
Journal of Addiction Psychiatry|September 11, 2025
Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and PresentKenneth Blum, Alireza Sharafshah, Jag Khalsa, et al.
Pageof 1